cisplatin

Cisplatin is a "first generation" antitumor drug highly effective in the chemotherapy of many forms of cancer. Thge metallodrug is most commonly used to treat testicular, bladder, lung, gullet (oesophagus), stomach and ovarian cancers. The water-soluble platinum complex, after hydrolysis, reacts with the nucleic acid bases of DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.
 
IUPAC name: cis-diamminedichloroplatinum(II).



The term "cisplatin" was found in the following pages:

Link database: DrugBank: Cisplatin
Link database: Lipoplatin -
Link database: Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins
Link database: ChemCases: Cisplatin: The Invention of an Anticancer Drug
Link database: Austria: University of Vienna: Institute of Inorganic Chemistry: Working group of B. Keppler
Link database: Cisplatin: Cancerbackup
Link database: DrugBank: Oxaliplatin
Scientific publications with participation of EVISA | EVISA's News
Link database: Australia: University of Western Sydney: Biologically Active Drugs by Design Group
Link database: Chemocare: Cisplatin
Species transformation during speciation analysis | EVISA's News
Link database: National Cancer Institute: Cisplatin
Speciation and Toxicity | EVISA's News
Nanoscale Metal-Organic Frameworks (NMOFs): A new way to create better MRI Contrast Agents | EVISA's News
Side effects of cisplatin chemotherpy: Platinum speciation matters | EVISA's News
Spatially resolved speciation analysis: A new technique based on laser ablation with simultaneous elemental and molecular mass spectrometry | EVISA's News
Copper molecule shows promise in fighting against cancer | EVISA's News
Brief summary: Speciation analysis for the study of metallodrugs and their biomolecular interactions | EVISA's News
„Forever young“ oder wirklich jung? - Metallomics im Fokus der Biochemie | EVISA's News
Metallomics 2011: Chemiker der Universität Münster laden zu Symposium über die Rolle von Metallen in Biologie und Medizin ein | EVISA's News